Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.068 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.054 | 0.7 |
mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.12 | 0.7 |